X

Trial Profile

Randomized Clinical Trial to Assess the Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lithium (Primary)
Indications Machado-Joseph Disease
Focus Adverse reactions; Therapeutic Use

Most Recent Events

30 Jul 2013 New trial record
20 Jun 2013 Primary endpoint 'Neurological-Examination-Score-for-Spinocerebellar-Ataxia' has not been met according to results presented at the 17th International Congress of Parkinson's Disease and Movement Disorders.
20 Jun 2013 Results presented at the 17th International Congress of Parkinson's Disease and Movement Disorders.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com